Keywords
How to Cite
Abstract
Complications of allogeneic hematopoietic stem cell transplantation (allo-HSCT) include variable engraftment times, acute (aGVHD) and chronic (cGVHD) graft-versus-host diseases, bacterial infections and reactivation of cytomegalovirus (CMV), among others. The existence of polymorphisms in non-HLA genes that encode pro-inflammatory cytokines such as tumor necrosis factor alpha (TNF) and interferon gamma (IFNG) would condition the appearance of these complications. The impact of polymorphic variants +1349 CAn of INFG gene and -308 G/A of TNF was evaluated on the engraftment and GVHD in 148 allo-HSCT recipients with sibling donors. In the multivariate analysis, the genotype CAno12/no12 (low production) of INFG (OR 3.9, p=0.003), bone marrow (BM) as source of progenitor cells (OR 4.6, p=0.013) and bacteremia (OR 3.0, p=0.033) maintained their predictive power with respect to late engraftment (≥15 days). Genotype of low IFNG production (OR 0.1, p=0.008), bacteremia (OR 3.3, p=0.048) and presence of CMV (OR 3.3, p=0.046) showed a significant association with aGVHD 3-4. And with respect to cGVHD, the genotype -308 GG (low production) of TNF (OR 3.3, p=0.038), PB as source (OR 5.0, p=0.028), myeloablative conditioning (OR 3.3, p=0.014) and previous aGVHD 2-4 (OR 2.6, p=0.029). Although it is necessary to confirm these findings, the genotype of lower IFNG production was associated with a later engraftment and less severe aGVHD and genotypes of lower TNF production was related to a higher incidence of cGVHD contributing to the development of complications in allo-HSCT.
References
2. Servais S et al. Long-term immune reconstitution and infection burden after mismatched hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2014; 20:507-17.
3. Ogonek J et al. Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation. Front Immunol. 2016; 7:507.
4. Coghill JM et al. Effector CD4+ T cells, the cytokines they generate and GVHD: something old and something new. Blood. 2011; 117:3268-76.
5. Markey KA et al. The biology of graft-versus-host disease: experimental systems instructing clinical practice. Blood. 2014; 124:354-62.
6. Saudemont A, Madrigal JA. Allogeneic T cells: maestro in the co-ordination of the immune response after hematopoietic stem cell transplantation. Haematologica 2014; 99:203-5.
7. Dickinson AM, Norden J. Non-HLA genomics: does it have a role in predicting haematopoietic stem cell transplantation outcome? Int J Immunogenet. 2015; 42:229-38.
8. Kroeger KM et al. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol. 1997; 34:391-399.
9. Dufour C et al. Homozygosis for (12) CA repeats in the first intron of the human IFN gamma gene
Declaración de conflictos de interés:
Los autores declaran que no poseen conflictos de interés.
is significantly associated with the risk of aplastic
anaemia in Caucasian population. Br J Haematol.
2004; 126:682-685.
10. Pravica V et al. A single nucleotide polymorphism
in the first intron of the human IFN-gamma gene:
absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production.
Hum Immunol. 2000; 61:863-6.
11. Hanssen JA et al. Defining genetic risk for GVHD
and mortality following allogeneic hematopoietic stem cell transplantation. Curr Opin Hematol.
2010; 17:483-92.
12. Mlynarczewska A et al. Lack of IFN-gamma 2/2 homozygous genotype independently of recipient age
and intensity of conditioning regimen influences the
risk of aGVHD manifestation after HLA-matched
sibling haematopoietic stem cell transplantation.
Bone Marrow Transplantation. 2004; 34:339-44.
13. Palau V et al. Interferon-gamma gene polymorphism associate with mortality and graft-versushost disease severity in HLA-matched sibling bone
marrow transplantation. Haematologica. 2016;101
(S1): Abstract 2125.
14. Solano C. EICH crónica y alo-trasplante de progenitores hematopoyético de sangre periférica. XLV
Reunión Nacional de la AEHH y XIX Congreso
Nacional de la SETH. Haematologica (ed. esp.)
2003, supl. 6.
15. Lee H et al. Predictive factors for rapid neutrophil
and platelet engraftment after allogenic peripheral
blood stem cell transplantation in patients with acute leukemia. Ann Hematol. 2013; 92:1685-93.
16. Socie G, Blazar B. Acute graft-versus-host disease: from the bench to the bedside. Blood. 2009;
114:4327-36.
17. Janeczko M et al. Immune recovery and the risk of
CMV/EBV reactivation in children post allogeneic
haematopoietic stem cell transplantation. Cent Eur
J Immunol. 2016; 41: 287-96.
18. Jaskula et al. Interferon Gamma 13-CA-Repeat Homozygous Genotype and a Low Proportion of CD41
Lymphocytes Are Independent Risk Factors for Cytomegalovirus Reactivation with a High Number of
Copies in Hematopoietic Stem Cell Transplantation
Recipients. Biol Blood Marrow Transplant. 2009;
15: 1296-1305.
All material published in the journal HEMATOLOGÍA (electronic and print version) is transferred to the Argentinean Society of Hematology. In accordance with the copyright Act (Act 11 723), a copyright transfer form will be sent to the authors of approved works, which has to be signed by all the authors before its publication. Authors should keep a copy of the original since the journal is not responsible for damages or losses of the material that was submitted. Authors should send an electronic version to the email: revista@sah.org.ar